Psilera Debuts Novel Synthetic Platform to Aid Discovery of Neuroplastogens in New Publication

Seminal peer-reviewed medicinal chemistry publication in ACS Omega demonstrates Psilera's ability to develop and synthesize compounds with new, customizable functional groups.TAMPA, Fla., June 23, 2026 /PRNewswire/ — Psilera, a leading biopharmaceutical company pioneering next-generation psychedelics and neuroplastogens, today…

Read the full release →

News provided by PR Newswire.